Basic info
Industry
biotechnology research
Sectors
Plaque Psoriasis
Biotechnology
Atopic Dermatitis
Topical Drugs
Inflammation
Bioscience
Pharmaceutical
Clinical Trials
Medical Dermatology
Health Diagnostics
Immunology
Therapeutics
Eczema
Drug Development
Biopharma
Commercialization
Date founded
2016
Funding rounds raised
Total raised
$225M
from 9 investors over 9 rounds
A
Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT) raised $225M on December 23, 2021
Investors: Solar Capital Ltd
A
Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT) raised $95M on October 22, 2019
Investors: Omega Funds, OrbiMed Advisors, RA Capital Management, L.P., Vivo Capital and Frazier Healthcare Partners
A
Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT) raised $58M on September 1, 2018
Investors: Frazier Healthcare Partners and OrbiMed Advisors
A
Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT) raised $14M on April 1, 2017
Investors: Frazier Healthcare Partners